Cheng Ming, Gross Michael L
Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117 Shandong, China.
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Acc Chem Res. 2025 Jan 21;58(2):165-176. doi: 10.1021/acs.accounts.4c00545. Epub 2025 Jan 5.
Protein higher-order structure (HOS) is key to biological function because the mechanisms of protein machinery are encoded in protein three-dimensional structures. Mass spectrometry (MS)-based protein footprinting is advancing protein structure characterization by mapping solvent-accessible regions of proteins and changes in H-bonding, thereby providing higher order structural information. Footprinting provides insights into protein dynamics, conformational changes, and interactions, and when conducted in a differential way, can readily reveal those regions that undergo conformational change in response to perturbations such as ligand binding, mutation, thermal stress, or aggregation. Building on firsthand experience in developing and applying protein footprinting, we provide an account of our progress in method development and applications.In the development section, we describe fast footprinting with reactive reagents (free radicals, carbenes, carbocations) with emphasis on fast photochemical oxidation of proteins (FPOP). The rates of the modifying reactions are usually faster than protein folding/unfolding, ensuring that the chemistry captures the change without biasing the structural information. We then describe slow, specific side-chain labeling or slow footprinting and hydrogen-deuterium exchange (HDX) to provide context for fast footprinting and to show that, with validation, these modifications can deliver valid structural information. One advantage of slow footprinting is that usually no special apparatus (e.g., laser, synchrotron) is needed. We acknowledge that no single footprint is sufficient, and complementary approaches are needed for structure comparisons.In the second part, we cover several of our footprinting applications for the study of biotherapeutics, metal-bound proteins, aggregating (amyloid) proteins, and integral membrane proteins (IMPs). Solving structural problems in these four areas is often challenging for other high-resolution approaches, motivating the development of protein footprinting as a complementary approach. For example, obtaining structural data for the bound and unbound forms of a protein requires that both forms are amenable for 3D structure determination. For problems of this type, information on changes in structure often provides an answer. For amyloid proteins, structures of the starting state (monomer) and the final fibril state are obtainable by standard methods, but the important structures causing disease appear to be those of soluble oligomers that are beyond high-resolution approaches because the mix of structures is polydisperse in number and size. Moreover, the relevant structures are those that occur in cell or in vivo, not in vitro, ruling out many current methods that are not up to the demands of working in complex milieu. IMPs are another appropriate target because they are unstable in water (in the absence of membranes, detergents) and may not retain their HOS during the long signal averaging needed for standard tools. Furthermore, the structural changes occurring in membrane transport or induced by drug binding or other interactions, for example, resist high resolution determination.We provide here an account on MS-based footprinting, broadly describing its multifaceted development, applications, and challenges based on our first-hand experience in fast and slow footprinting and in HDX. The Account is intended for investigators contemplating the use of these tools. We hope to catalyze refinements in methods and applications through collaborative, cross-disciplinary research that involves organic and analytical chemists, material scientists, and structural biologists.
蛋白质高阶结构(HOS)对于生物学功能至关重要,因为蛋白质机制编码于蛋白质的三维结构中。基于质谱(MS)的蛋白质足迹分析正通过绘制蛋白质的溶剂可及区域和氢键变化来推进蛋白质结构表征,从而提供高阶结构信息。足迹分析有助于深入了解蛋白质动力学、构象变化和相互作用,并且以差异方式进行时,能够轻松揭示那些因配体结合、突变、热应激或聚集等扰动而发生构象变化的区域。基于在开发和应用蛋白质足迹分析方面的第一手经验,我们阐述了我们在方法开发和应用方面取得的进展。
在开发部分,我们描述了使用反应性试剂(自由基、卡宾、碳正离子)进行的快速足迹分析,重点介绍了蛋白质的快速光化学氧化(FPOP)。修饰反应的速率通常比蛋白质折叠/解折叠的速率快,确保化学反应能够捕捉到变化而不会对结构信息产生偏差。然后,我们描述了缓慢的、特异性侧链标记或缓慢足迹分析以及氢-氘交换(HDX),以为快速足迹分析提供背景,并表明经过验证,这些修饰能够提供有效的结构信息。缓慢足迹分析的一个优点是通常不需要特殊设备(例如激光、同步加速器)。我们认识到单一的足迹分析并不足够,需要互补的方法进行结构比较。
在第二部分,我们介绍了我们在生物治疗药物、金属结合蛋白、聚集(淀粉样)蛋白和整合膜蛋白(IMP)研究中的几个足迹分析应用。对于其他高分辨率方法而言,解决这四个领域的结构问题通常具有挑战性,这促使蛋白质足迹分析作为一种互补方法得到发展。例如,要获得蛋白质结合态和未结合态的结构数据,需要确保两种状态都适合进行三维结构测定。对于这类问题,结构变化的信息通常能提供答案。对于淀粉样蛋白,起始状态(单体)和最终纤维状态的结构可通过标准方法获得,但导致疾病发生变化的重要结构似乎是可溶性寡聚体的结构,这些结构超出了高分辨率方法的范围,因为其结构在数量和大小上具有多分散性。此外,相关结构是在细胞或体内出现的,而非体外,这排除了许多当前无法满足在复杂环境中工作要求的方法。IMP是另一个合适的目标,因为它们在水中(无膜、无去污剂时)不稳定,并且在标准工具所需的长时间信号平均过程中可能无法保持其高阶结构。此外,例如在膜运输过程中发生的或由药物结合或其他相互作用诱导的结构变化,难以通过高分辨率测定。
我们在此阐述基于MS的足迹分析,基于我们在快速和缓慢足迹分析以及HDX方面的第一手经验广泛描述其多方面的发展、应用和挑战。本综述旨在供考虑使用这些工具的研究人员参考。我们希望通过涉及有机和分析化学家、材料科学家以及结构生物学家的合作性跨学科研究来推动方法和应用的改进。